A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus - a systematic review and meta-analysis
Author:
Affiliation:
1. HTA Consulting; Krakow Poland
2. Novo Nordisk Pharma; Warsaw Poland
3. Department of Metabolic Diseases; Jagiellonian University Medical College; Krakow Poland
4. University Hospital; Krakow Poland
Publisher
Hindawi Limited
Subject
General Medicine
Reference46 articles.
1. Standards of medical care in diabetes-2011;American Diabetes Association;Diabetes Care,2011
2. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes;Patel;N Engl J Med,2008
3. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus;Reichard;N Engl J Med,1993
4. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes;World Journal of Diabetes;2023-03-15
2. Long‐acting Insulin Analogues;Diabetes Drug Notes;2022-06-27
3. Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring;Journal of Clinical Medicine;2021-05-05
4. Diabetes mellitus type 2 in adults;Diabetes mellitus;2020-06-22
5. Insulin Therapy in Type 2 Diabetes;American Journal of Therapeutics;2020-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3